-
-
The Role of Evidence
Defining Markets, Demonstrating Value, Informing Product Lifecycles
The increasing emphasis on evidence in international health care has profound implications for companies in the life sciences industries, informing their approach to market access and driving their strategies with regard to outcomes research, pricing, and reimbursement.
Our consultants have contributed to various discussions about evidence – from presenting on comparative effectiveness research at the annual meetings of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and other conferences, to addressing the role of evidence in pricing and reimbursement strategies in industry publications and peer-reviewed journals.
-
-
Health Care Bulletin
Enhancing Product Value Propositions in the Pipeline
There are significant opportunities to integrate market access into product development decisions in early phases. Read about the use of value analytics to forecast market access outcomes and risk-sharing in the pipeline.
-
Health Care Bulletin
Methods for Indirect Comparisons in Outcomes Research
Managing Principal Eric Q. Wu and Principal James Signorovitch discuss the methods for indirect comparisons in outcomes research.